iSpecimen Inc. reports developments tied to its online marketplace for human biospecimens, which connects life science researchers with a network of healthcare specimen providers. Company updates cover biospecimen sourcing for research projects, supplier-network responsiveness, direct-to-customer shipping, and marketplace technology used to match customer requests with available inventory.
Recurring news themes include AI-assisted inventory matching, SalesStack marketplace integration, respiratory and other specimen procurement, international sourcing relationships, and capital-structure actions such as the completed reverse stock split of ISPC common stock.
iSpecimen, an online marketplace for human biospecimens, announced the pricing of its initial public offering (IPO) of 2,250,000 shares at $8.00 per share, raising $18 million before expenses. The offering includes a 45-day option for underwriters to buy an additional 337,500 shares. Trading is set to begin on the Nasdaq under the symbol 'ISPC' on June 17, 2021, with the offering expected to close on June 21, 2021. Proceeds will fund technology development, marketing, and debt repayment.